These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9049191)

  • 1. Nitric oxide does not reverse pulmonary hypertension associated with end-stage liver disease: a preliminary report.
    Ramsay MA; Schmidt A; Hein HA; Nguyen AT; Lynch K; East CA; Ramsay KJ; Klintmalm GB
    Hepatology; 1997 Mar; 25(3):524-7. PubMed ID: 9049191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
    Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
    J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates.
    Radovancevic B; Vrtovec B; Thomas CD; Croitoru M; Myers TJ; Radovancevic R; Khan T; Massin EK; Frazier OH
    J Heart Lung Transplant; 2005 Jun; 24(6):690-5. PubMed ID: 15949728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled nitric oxide: effects on hemodynamics, myocardial contractility, and regional blood flow in dogs with mechanically induced pulmonary artery hypertension.
    Girard C; Fargnoli JM; Godin-Ribuot D; Dutheil V; Maitrasse B; Girardet P; Arvieux CC
    J Heart Lung Transplant; 1996 Jul; 15(7):700-8. PubMed ID: 8820786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled nitric oxide through a noninvasive ventilation device to assess reversibility of pulmonary hypertension in selecting recipients for heart transplant.
    Fojón S; Fernández-González C; Sánchez-Andrade J; López-Pérez JM; Hermida LF; Rodríguez JA; Juffé A
    Transplant Proc; 2005 Nov; 37(9):4028-30. PubMed ID: 16386617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative epoprostenol and nitric oxide for severe pulmonary hypertension during orthotopic liver transplantation: a case report and review of the literature.
    Vater Y; Martay K; Dembo G; Bowdle TA; Weinbroum AA
    Med Sci Monit; 2006 Dec; 12(12):CS115-118. PubMed ID: 17136012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhalation nitric oxide during heart transplantation].
    Kozlov IA; Poptsov VN
    Anesteziol Reanimatol; 1999; (5):9-14. PubMed ID: 10560143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
    Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
    Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled nitric oxide reduction in systolic pulmonary artery pressure is less in patients with decreased left ventricular ejection fraction.
    Cujec B; Hurst T; McCuaig R; Antecol D; Mayers I; Johnson D
    Can J Cardiol; 1997 Sep; 13(9):816-24. PubMed ID: 9343030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of nitric oxide administration on pateints with pulmonary hypertension: a dose-response study].
    He J; Cheng X; Xiong C
    Zhonghua Yi Xue Za Zhi; 1998 Feb; 78(2):105-6. PubMed ID: 10923418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension.
    Findlay JY; Harrison BA; Plevak DJ; Krowka MJ
    Liver Transpl Surg; 1999 Sep; 5(5):381-7. PubMed ID: 10477839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use.
    Krasuski RA; Wang A; Harrison JK; Tapson VF; Bashore TM
    Am Heart J; 2005 Oct; 150(4):725-8. PubMed ID: 16209974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension.
    Braun S; Schrötter H; Schmeisser A; Strasser RH
    Int J Cardiol; 2007 Jan; 115(1):67-72. PubMed ID: 16797747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
    Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
    Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
    Khan TA; Schnickel G; Ross D; Bastani S; Laks H; Esmailian F; Marelli D; Beygui R; Shemin R; Watson L; Vartapetian I; Ardehali A
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term inhaled nitric oxide plus phosphodiesterase 5 inhibitors for severe pulmonary hypertension.
    Pérez-Peñate GM; Juliá-Serdà G; Ojeda-Betancort N; García-Quintana A; Pulido-Duque J; Rodríguez-Pérez A; Cabrera-Navarro P; Gómez-Sánchez MA
    J Heart Lung Transplant; 2008 Dec; 27(12):1326-32. PubMed ID: 19059113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does inhaled nitric oxide improve survival in operated congenital disease with severe pulmonary hypertension?
    Sharma R; Raizada N; Choudhary SK; Bhan A; Kumar P; Juneja R; Kothari SS; Saxena A; Venugopal P
    Indian Heart J; 2001; 53(1):48-55. PubMed ID: 11456141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined administration of intravenous dipyridamole and inhaled nitric oxide to assess reversibility of pulmonary arterial hypertension in potential cardiac transplant recipients.
    Lepore JJ; Dec GW; Zapol WM; Bloch KD; Semigran MJ
    J Heart Lung Transplant; 2005 Nov; 24(11):1950-6. PubMed ID: 16297803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation.
    Krowka MJ; Plevak DJ; Findlay JY; Rosen CB; Wiesner RH; Krom RA
    Liver Transpl; 2000 Jul; 6(4):443-50. PubMed ID: 10915166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive use of inhaled nitric oxide during implantation of a left ventricular assist device.
    Macdonald PS; Keogh A; Mundy J; Rogers P; Nicholson A; Harrison G; Jansz P; Kaan AM; Spratt P
    J Heart Lung Transplant; 1998 Mar; 17(3):312-6. PubMed ID: 9563609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.